The GLP-1 drugs are the latest class to show a benefit in patients, this time with OSA, but like other tools have nontrivial side effects, cost concerns, and patient persistence issues that balance out the headline benefits. The size of the underlying patient populations, which are expected to surpass 1.3 billion globally by 2050, as well as the under penetration of CPAP treatment, which Andrew ballparks at 15% or less in many markets, reinforces the analysts argument
How to save on GLP-1 and GIP/GLP-1 receptor agonists The best way to save on GLP-1 and GIP/GLP-1 receptor agonists is by using your health insurance
Is a mouse finding being presented as a human benefit
What it Does: A multi-vitamin focused blend that works on the skins surface quality while simultaneously brightening the overall tone
Here are five lifestyle changes that can help you get the most glutathione benefits
This guide explains what is known, what is not, and what to discuss with your metabolic health physician